is ozempic tirzepatide or semaglutide Ozempic® (semaglutide) and Mounjaro™ (tirzepatide), a major breakthrough for the treatment of obesity Tirzepatide vs Semaglutide for Weight

Aggregated S in turn reciprocally worsens mitochondrial stress and sirtuin loss, locking the system into a degenerative cycle that culminates in dopaminergic neuronal loss

Similarly, while some weight loss drugs focus on appetite, retatrutides more expansive mechanism helps fuel maintainable fat loss

34 Hu et al

[DOI] [PMC free article] [PubMed] [Google Scholar] 327.Portha, B., Tourrel-Cuzin, C

Like other incretin-based medications, the most common side effects were gastrointestinal: Common Side Effects Nausea: Reported in approximately 25-45% of participants depending on dose (most common during titration) Diarrhea: Approximately 20-35% of participants Vomiting: Approximately 10-20% of participants Constipation: Approximately 10-15% of participants Decreased appetite: Common and expected given the mechanism of action Less Common but Notable Effects Increased heart rate: Small elevations in resting heart rate were observed, consistent with other GLP-1 class medications Injection site reactions: Mild redness or itching at injection sites Fatigue: Reported by some participants, particularly during dose escalation Most adverse events were mild to moderate and occurred primarily during the dose escalation phase

This effect may be most prominent early in treatment and can diminish over time with long-acting GLP-1 RAs